SCHEMBL4155504

SCHEMBL4155504

FC(F)(F)c1cccc(/C=C/c2ccccc2)c1-c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
SCN5A Q14524 2/20 0.40
SCN9A Q15858 2/20 0.40
NFE2L2 Q16236 2/20 0.40
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
KDM1A O60341 2/20 0.37
KDM4E B2RXH2 4/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
TRPA1 O75762 1/20 0.37
CYP24A1 Q07973 1/20 0.36
CCR1 P32246 2/20 0.36
CCR5 P51681 2/20 0.36
CCR8 P51685 2/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
METAP1 P53582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4155506 1.00 LMNA (0.41) LMNASCN5ASCN9ANFE2L2PDCD1
SCHEMBL4165025 0.85 KDM4E (0.46) LMNANFE2L2KDM1AKDM4ENPC1
SCHEMBL4165023 0.85 KDM4E (0.46) LMNANFE2L2KDM1AKDM4ENPC1
SCHEMBL7646425 0.81 SCN5A (0.44) LMNASCN5ASCN9ANFE2L2KDM4E
SCHEMBL28565356 0.80 KDM1A (0.48) LMNANFE2L2KDM1AKDM4ENPC1
SCHEMBL4155639 0.78 L3MBTL1 (0.41) LMNANFE2L2KDM1AKDM4ENPC1
SCHEMBL4155634 0.78 L3MBTL1 (0.41) LMNANFE2L2KDM1AKDM4ENPC1
SCHEMBL5492352 0.76 NFKB1 (0.56) NFE2L2RAB9ATRPA1NFKB1
SCHEMBL5492342 0.76 NFKB1 (0.56) NFE2L2RAB9ATRPA1NFKB1
SCHEMBL4159067 0.74 NFE2L2 (0.59) LMNANFE2L2KDM4ENPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8212048-B2 Method of producing aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-03 US disclosed
US-8212048-B2 Method of producing aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-03 US disclosed
US-8212048-B2 Method of producing aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-03 US disclosed
CN-101410375-B Process for producing aromatic compound SUMITOMO CO LTD 2012-06-13 CN disclosed
CN-101410375-A Process for producing aromatic compound SUMITOMO CHEMICAL CO (JP) 2009-04-15 CN disclosed
US-20090043096-A1 METHOD OF PRODUCING AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-12 US disclosed
US-20090043096-A1 METHOD OF PRODUCING AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-12 US disclosed
US-20090043096-A1 METHOD OF PRODUCING AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090043096-A1 METHOD OF PRODUCING AROMATIC COMPOUND AHR, CYP1A1, ARNT LMNA 2466/4885SCN5A 3219/4885SCN9A 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.